Congress is considering a bill that could deter billions of dollars of medical research investments, undermining U.S. global leadership as a healthcare innovator and harming U.S. patients That’s not Congress’s intent, of course. Lawmakers are trying to fix perceived abuses of the patent system that — supposedly — block cheaper generic drugs from reaching the […]